Johnson & Johnson lands in Washington the week of a major FDA approval and a pipeline milestone

Johnson & Johnson flew from Trenton Mercer Airport to Ronald Reagan Washington National Airport on May 14, a 44-minute hop in its Gulfstream G650ER, tail N400J. The short trip from New Jersey to the capital suggests a day trip for regulatory or policy meetings.

The same week, Johnson & Johnson announced the FDA approval of STELARA for pediatric Crohn's disease, per a company press release on May 1, and reported strong Q1 2026 earnings on April 14, raising its full-year outlook. The company also presented late-breaking data at Digestive Disease Week in Chicago on May 5, including promising results for its investigational co-antibody therapy JNJ-4804 and a study showing TREMFYA efficacy in perianal fistulizing Crohn's disease, as covered by CNBC. Washington is where the company engages with regulators and policymakers on these approvals and pipeline advances.

The flight follows a pattern of recent trips between New Jersey and the Washington area, including a round trip on May 7. Johnson & Johnson's mixed fleet, including this G650ER, is frequently used for executive travel between its New Brunswick headquarters and key destinations like Washington, New York, and European hubs for investor meetings and regulatory affairs.